Clinically Evaluated COVID-19 Drugs with Therapeutic Potential for Biological Warfare Agents

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak resulted in hundreds of millions of coronavirus cases, as well as millions of deaths worldwide. Coronavirus Disease 2019 (COVID-19), the disease resulting from exposure to this pathogen, is characterized, among other features,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dechtman, Ido-David, Ankory, Ran, Sokolinsky, Keren, Krasner, Esther, Weiss, Libby, Gal, Yoav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304720/
https://www.ncbi.nlm.nih.gov/pubmed/37375079
http://dx.doi.org/10.3390/microorganisms11061577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304720/
https://www.ncbi.nlm.nih.gov/pubmed/37375079
http://dx.doi.org/10.3390/microorganisms11061577

Ejemplares similares